Skip to main content
CivixlyCivixly
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Account
Menu
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Account
Civixly

Find representatives, follow federal and state legislation, and connect public records to the people and institutions responsible for them.

Explore

Federal governmentState governmentCivics guidesInstall Civixly

About the data

About CivixlyMethodologyData sources

Trust and support

Send feedback or a correctionPrivacy and data controlsSecurity contactCommunity

State Government / New Hampshire / Legislation / SB 256

SB 256Session 2026SenatePassed a vote

establishing safety and care requirements for clinician-administered drugs.

No separate plain-language summary is currently available from the source.

Latest development · Oct 1, 2026

Executive Session: 10/14/2026 10:00 am GP 229

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Source record ↗
Session
2026
Introduced
Jan 23, 2025
Latest passage
Jan 7, 2026
TopicsSponsorsActionsDiscussion

Topics and classification

Document type

Bill

Sponsors

Primary sponsors are listed before cosponsors and other sponsoring entities.

cosponsorJohn Michael Potucek

Action timeline

Newest action first. Action language is supplied by the state source.

View full action timeline18 actions⌄
  1. Oct 1, 2026

    Executive Session: 10/14/2026 10:00 am GP 229

    House
  2. Sep 17, 2026

    Subcommittee Work Session: 10/07/2026 10:00 am GP 229

    House
  3. Aug 21, 2026

    Subcommittee Work Session: 09/09/2026 10:00 am GP 229

    House
  4. May 14, 2026

    Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2

    House
  5. May 1, 2026

    Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6

    House
  6. Apr 22, 2026

    Executive Session: 04/29/2026 10:00 am GP 229

    House
  7. Apr 16, 2026

    Subcommittee Work Session: 04/22/2026 10:00 am GP 229

    House
  8. Apr 2, 2026

    Public Hearing: 04/07/2026 02:15 pm GP 159

    House
  9. Apr 1, 2026

    Subcommittee Work Session: 04/08/2026 10:00 am GP 229

    House
  10. Mar 2, 2026

    Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127

    Referral CommitteeHouse
  11. Feb 26, 2026

    Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124

    IntroductionReferral CommitteeHouse
  12. Jan 7, 2026

    Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1

    Committee Passage FavorablePassageSenate
  13. Jan 7, 2026

    Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1

    Senate
  14. Oct 22, 2025

    Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46

    Committee Passage FavorableSenate
  15. Mar 6, 2025

    Rereferred to Committee, MA, VV; 03/06/2025; SJ 6

    Referral CommitteeSenate
  16. Feb 21, 2025

    Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11

    Senate
  17. Feb 5, 2025

    Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9

    Senate
  18. Jan 23, 2025

    Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3

    IntroductionReferral CommitteeSenate

SB 256 discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

State legislative data provided by Open States and linked legislature sources when available.

Civixly tracks state bill actions, passage dates, and sponsors. Member-level state roll-call histories are not included.

Source data last updated Oct 14, 2026.